Lancet Neurol · 2015

Neuroinflammation in Alzheimer's disease

Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, Herrup K, Frautschy SA, Finsen B, Brown GC, Verkhratsky A, Yamanaka K, Koistinaho J, Latz E, Halle A, Petzold GC, Town T, Morgan D, Shinohara ML, Perry VH, Holmes C, Bazan NG, Brooks DJ, Hunot S, Joseph B, Deigendesch N, Garaschuk O, Boddeke E, Dinarello CA, Breitner JC, Cole GM, Golenbock DT, Kummer MP.

Show affiliations

Heneka MT — Department of Neurology, University Hospital Bonn, University of Bonn, Bonn, Germany; German Center for Neurodegnerative Diseases (DZNE), Bonn, Germany. Electronic address: michael.heneka@ukb.uni-bonn.de.
Carson MJ — Division of Biomedical Sciences, Center for Glial-Neuronal Interactions, University of California, Riverside, CA, USA.
El Khoury J — Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA.
Landreth GE — Alzheimer Research Laboratory, Department of Neurosciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Brosseron F — German Center for Neurodegnerative Diseases (DZNE), Bonn, Germany.
Feinstein DL — Department of Anesthesiology, University of Illinois, Chicago, IL, USA.
Jacobs AH — Department of Geriatrics, Johanniter Hospital, Bonn, Germany; European Institute for Molecular Imaging (EIMI) at the Westfalian Wilhelms University (WWU), Münster, Germany.
Wyss-Coray T — Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA; Center for Tissue Regeneration, Repair, and Restoration, VA Palo Alto Health Care System, Palo Alto, CA, USA.
Vitorica J — Instituto de Biomedicina de Sevilla (IBIS), Hospital Universitario Virgen del Rocio, Consejo Superior de Investigaciones Cientificas Universidad de Sevilla, Sevilla, Spain.
Ransohoff RM — Department of Neuroscience, Neuroinflammation Research Center, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Herrup K — Division of Life Science, Hong Kong University of Science and Technology, Hong Kong.
Frautschy SA — Department of Neurology, David Geffen School of Medicine at the University of California, Los Angeles, the Geriatric, Research, and Clinical Center, Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles, CA, USA.
Finsen B — Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
Brown GC — Department of Biochemistry, University of Cambridge, Cambridge, UK.
Verkhratsky A — Faculty of Life Sciences, The University of Manchester, Manchester, UK; Achucarro Center for Neuroscience, Basque Foundation for Science (IKERBASQUE), Bilbao, Spain; Department of Neurosciences, University of the Basque Country UPV/EHU (Euskal Herriko Unibertsitatea/Universidad del País Vasco) and CIBERNED (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas), Leioa, Spain.
Yamanaka K — Research Institute of Environmental Medicine, Nagoya University/RIKEN Brain Science Institute, Wako-shi, Japan.
Koistinaho J — Department of Neurobiology, AI Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Latz E — German Center for Neurodegnerative Diseases (DZNE), Bonn, Germany; Institute of Innate Immunity, University of Bonn, Bonn, Germany; Department of InfectiousDiseases and Immunology, University of Massachusetts Medical School, Worcester, MA, USA.
Halle A — Max-Planck Research Group Neuroimmunology, Center of Advanced European Studies and Research (CAESAR), Bonn, Germany.
Petzold GC — Department of Neurology, University Hospital Bonn, University of Bonn, Bonn, Germany; German Center for Neurodegnerative Diseases (DZNE), Bonn, Germany.
Town T — Zilkha Neurogenetic Institute, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA.
Morgan D — Department of Molecular Pharmacology and Physiology, Byrd Alzheimer's Institute, University of South Florida College of Medicine, Tampa, FL, USA.
Shinohara ML — Department of Immunology, Duke University Medical Center, Durham, NC, USA.
Perry VH — School of Biological Sciences, Southampton General Hospital, Southampton, UK.
Holmes C — Clinical and Experimental Science, University of Southampton, Southampton, UK; Memory Assessment and Research Centre, Moorgreen Hospital, Southern Health Foundation Trust, Southampton, UK.
Bazan NG — Louisiana State University Neuroscience Center of Excellence, Louisiana State University Health Sciences Center School of Medicine in New Orleans, LA, USA.
Brooks DJ — Division of Experimental Medicine, Imperial College London, Hammersmith Hospital, London, UK.
Hunot S — Centre National de la Recherche Scientifique (CNRS), UMR 7225, Experimental Therapeutics of Neurodegeneration, Paris, France.
Joseph B — Department of Oncology Pathology, Cancer Centrum Karolinska, Karolinska Institutet, Stockholm, Sweden.
Deigendesch N — Department of Cellular Microbiology, Max Planck Institute for Infection Biology, Berlin, Germany.
Garaschuk O — Institute of Physiology II, Eberhard Karls University of Tübingen, Tübingen, Germany.
Boddeke E — Department of Neuroscience, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands.
Dinarello CA — Department of Medicine, University of Colorado Denver, Aurora, CO, USA.
Breitner JC — Centre for Studies on Prevention of Alzheimer's Disease, Douglas Mental Health University Institute, and the McGill University Faculty of Medicine, Montreal, Quebec, Canada.
Cole GM — Department of Neurology, David Geffen School of Medicine at the University of California, Los Angeles, the Geriatric, Research, and Clinical Center, Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles, CA, USA.
Golenbock DT — Department of InfectiousDiseases and Immunology, University of Massachusetts Medical School, Worcester, MA, USA.
Kummer MP — Department of Neurology, University Hospital Bonn, University of Bonn, Bonn, Germany.